The novel retinoid, 9cUAB30, inhibits telomerase and induces apoptosis in HL60 cells

Translational Oncology

Volumn 1, Issue 3, 2008, Pages 148-152

  Love, William K ^a   Tyson DeAngelis, J ^a   Berletch, Joel B ^a   Phipps, Sharla M O ^a   Andrews, Lucy G ^a   Brouillette, Wayne J ^a   Muccio, Donald D ^a   Tollefsbol, Trygve O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61449095186     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08142     Document Type: Article

References (24)

1. Shay J and Bacchetti S (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33, 787-791.
2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, and Shay JW (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011.
3. Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, and Segal-Bendirdjian E (2001). Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc Natl Acad Sci USA 98, 6662-6667.
4. Xu D, Gruber A, Björkholm M, Peterson C, and Pisa P (1999). Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer 80, 1156-1161.
5. Sporn M and Roberts A (1983). Role of retinoids in differentiation and carcinogenesis. Cancer Res 43, 3034-3040.
6. Reichman T, Albanell J, Wang X, Moore M, and Studzinski G (1997). Down-regulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem 67, 13-23.
7. Choi S, Kang H, Im E, Kim Y, Bae Y, Choi Y, Lee K, Chung H, Chang H, and Kim N (2000). Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids. Int J Oncol 17, 971-976.
8. Sanborn C, O'Connor A, Sawin R, Moore K, Dehart M, and Azarow K (2000). Comparison of telomerase levels before and after differentiation of two cell lines of human neuroblastoma. J Surg Res 93, 206-210.
9. Ding Z, Green A, Yang X, Chernenko G, Tang S, and Pater A (2002). Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Exp Cell Res 272, 185-191.
10. Casillas M, Brotherton S, Andrews L, Ruppert J, and Tollefsbol T (2003). Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316, 57-65.
11. Lo Coco F, Nervi C, Avvisati G, and Mandelli F (1998). Acute promyelocytic leukemia: a curable disease. Leukemia 12, 1866-1880.
12. Mangelsdorf D (1994). Vitamin A receptors. Nutr Rev 52, S32-S44.
13. Poole J, Andrews L, and Tollefsbol T (2001). Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269, 1-12.
14. Muccio D, Brouillette W, Alam M, Vaezi M, Sani B, Venepally P, Reddy L, Li E, Norris A, Simpson-Herren L, et al. (1996). Conformationally defined 6-s-transretinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity. J Med Chem 39, 3625-3635.
15. Muccio D, Brouillette W, Breitman T, Taimi M, Emanuel P, Zhang X, Chen G, Sani B, Venepally P, Reddy L, et al. (1998). Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias. J Med Chem 41, 1679-1687.
16. Grubbs C, Hill D, Bland K, Beenken S, Lin T, Eto I, Atigadda V, Vines K, Brouillette W, and Muccio D (2003). 9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers. Cancer Lett 201, 17-24.
17. Grubbs C, Lubet R, Atigadda V, Christov K, Deshpande A, Tirmal V, Xia G, Bland K, Eto I, Brouillette W, et al. (2006). Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers. Carcinogenesis 27, 1232-1239.
18. Elmore L, Forsythe H, Ferreira-Gonzalez A, Garrett C, Clark G, and Holt S (2002). Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay. Diagn Mol Pathol 11, 177-185.
19. Saldanha S, Andrews L, and Tollefsbol T (2003). Analysis of telomerase activity and detection of its catalytic subunit, hTERT. Anal Biochem 315, 1-21.
20. Tollefsbol T and Andrews L (2001). Mechanisms for telomerase gene control in aging cells and tumorigenesis. Med Hypotheses 56, 630-637.
21. Kizaki M, Dawson M, Heyman R, Elster E, Morosetti R, Pakkala S, Chen D, Ueno H, Chao W, Morikawa M, et al. (1996). Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Blood 87, 1977-1984.
22. Chen Z (1996). Differentiation therapy of acute promyelocytic leukemia. Chin Med J (Engl) 109, 179-182.
23. Zhang X, Hoffmann B, Tran P, Graupner G, and Pfahl M (1992). Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355, 441-446.
24. Hansen NJ, Wylie RC, Phipps SM, Love WK, Andrews LG, and Tollefsbol TO (2007). The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells. Int J Oncol 30, 641-650.